Based on the analysis of 204 patients with endometrial cancer who underwent germline multigene panel testing, we investigated the prevalence of LS and non-LS mutation and the relative contribution of each MMR gene mutation that, in composite, led to the clinical phenotype of LS-associated endometrial cancer patients in a predominantly Korean population. Here, MRC1 is linked to endometrial cancer.